Neuropace, Inc. (NASDAQ: NPCE)
$11.8650
-0.5550 ( -4.39% ) 34.7K
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
Market Data
Open
$11.8650
Previous close
$12.4200
Volume
34.7K
Market cap
$357.73M
Day range
$11.7500 - $12.6400
52 week range
$5.4500 - $18.1500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Nov 12, 2024 |
| 10-q | Quarterly Reports | 64 | Nov 12, 2024 |
| 4 | Insider transactions | 1 | Oct 28, 2024 |
| 4 | Insider transactions | 1 | Oct 24, 2024 |
| 4 | Insider transactions | 1 | Oct 22, 2024 |
| 4 | Insider transactions | 1 | Oct 18, 2024 |
| 4 | Insider transactions | 1 | Oct 03, 2024 |
| 8-k | 8K-related | 15 | Aug 13, 2024 |
| 10-q | Quarterly Reports | 64 | Aug 13, 2024 |
| 4 | Insider transactions | 2 | Jun 11, 2024 |